Obesity is associated with a higher incidence of rejection in patients on belatacept: a pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials

Congratulations to Dr. Nicholas Lange on your public disclosure, “Obesity is associated with a higher incidence of rejection in patients on belatacept: a pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials.” #ClinicalResearch https://t.co/nGDSfB0O

That’s interesting! Do they need a higher dose?

RT @amjtransplant: Brief Communication by Lange et al, "Obesity is associated with a higher incidence of rejection in patients on belatacep…

Congratulations to #NickLange @nyphospital @SumitMohanMD @demetratsapepas @SAHusainMD @TxpPRN